• news.cision.com/
  • PainDrainer/
  • PainDrainer is selected to Creative Destruction Lab’s Digital Society program for massively scalable science- and technology-based companies
Svenska

PainDrainer is selected to Creative Destruction Lab’s Digital Society program for massively scalable science- and technology-based companies

Report this content

LUND, SWEDEN – PainDrainer AB has after a selection process been chosen to take part in the 9-month program with the aim to successfully scale the business.

Creative Destruction Lab (CDL) is a non-profit organization that delivers an objectives-based program for massively scalable, science- and technology-based companies. As part of the program PainDrainer will get the opportunity work with an outstanding team of international mentors, advisors, investors, industry, and research leaders.

“This is a fantastic opportunity for PainDrainer in our journey to help millions of people living with chronic pain. We have a digital tool with clinical evidence which can change the way to aid people living with chronic pain. To get direct expertise in how to best scale the business, with focus on the B2B market, is very valuable in our coming expansion”, says Erik Frick, CEO PainDrainer AB.

For more information, please contact:
Erik Frick
CEO PainDrainer AB
erik.frick@paindrainer.com
+46 736 612123

About PainDrainer AB
PainDrainer AB is a company developing digital platforms and applications contributing to health and well-being. PainDrainer was founded in 2018 by Prof. Carl Borrebaeck, Dr. Maria Klement (chronic pain patient herself), and Göran Barkfors (IT specialist). The idea was born when Maria, after participating in several pain rehabilitation programs, realized that the pain is affected by more factors than the human brain can keep track of, since all days are different. PainDrainer® uses advanced calculations based on artificial intelligence to coach the user in planning their day not to exceed a certain pain level, and to ensure that there is energy left for activities highly valued.

PainDrainer® has clinical evidence, is based on Acceptance and Commitment Therapy (ACT), self-management and artificial intelligence (AI). It is CE certified and is cleared by FDA as a Mobile Medical Device class 1 with exemption. www.paindrainer.com

Prenumerera